2m 2m 2m 2m 2m 2m 2m
NEWCELX N (NCEL)
NASDAQ
$3.17-$0.15 (-4.67%)
Price as of Jun 03, 2026 6:58 PM EDT- $23.6MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
NEWCELX N (NCEL)
$3.17-$0.15 (-4.67%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | 10.0M N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 +100.00% | -10.0M N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -1.1M +166.79% | -422,051 -92.86% | -5.9M -34.18% | -9.0M +51.65% | |
Depreciation and Amortization Expense | 55,000 +1,556.13% | 3,321 -70.89% | 11,408 0.00% | 11,408 +13.51% | |
Total Operating Expenses | 88,000 -97.99% | 4.4M -62.90% | 11.8M -23.74% | 15.5M +30.54% | |
Operating Profit | -2.6M -41.51% | -4.4M -62.90% | -11.8M -23.74% | -15.5M +30.54% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -119,920 +2,020.60% | -5,655 -71.77% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -119,920 +2,020.60% | -5,655 -71.77% | |
Total Nonoperating Income and Expense | -5.7M -339.15% | 2.4M +1,191.53% | -219,812 -2,288.27% | 10,045 +157.99% | |
Income before Taxes | -8.3M +104.59% | -4.1M -65.64% | -11.8M -23.74% | -15.5M +30.54% | |
Income Taxes | N/A N/A | 270,668 -68.25% | 852,486 -15.15% | 1.0M -10.27% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -8.3M +319.02% | -2.0M -83.73% | -12.2M -26.21% | -16.5M +38.08% | |
Net Income from Continuing Operations Applicable to Common | 8.3M +304.59% | -4.1M -66.67% | -12.2M -26.21% | -16.5M +38.08% | |
Basic EPS and Net Income | 2.16 +182.13% | -2.63 +721.88% | -0.32 -61.90% | -0.84 N/A | |
Diluted EPS and Net Income | 2.16 +182.13% | -2.63 +721.88% | -0.32 -61.90% | -0.84 -16.00% | |
Basic Weighted Average Shares | 3.8M +149.08% | 1.5M -95.96% | 38.2M +93.96% | 19.7M +65.38% | |
Diluted Weighted Average Shares | 3.8M +149.08% | 1.5M -95.96% | 38.2M +93.96% | 19.7M +65.38% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.2M +32.16% | 1.7M +85.52% | 897,680 -89.97% | 8.9M +64.76% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.2M +32.16% | 1.7M +85.52% | 897,680 -89.97% | 8.9M +64.76% | |
Total Current Assets | 3.2M +42.98% | 2.2M +22.08% | 1.8M -80.28% | 9.2M +61.56% | |
Accumulated Depreciation | 1.6M +4,409.91% | 36,187 +10.10% | 32,866 +188.10% | 11,408 +13.51% | |
Property and Plant and Equipment and Net | 95,000 +1,203.16% | 7,290 +8.90% | 6,694 -63.02% | 18,102 -38.66% | |
Total Long-Term Assets | 8.3M +2,919,687.99% | 283 -98.32% | 16,885 +39.05% | 12,143 +0.82% | |
Total Assets | 11.4M +412.51% | 2.2M +20.93% | 1.8M -80.09% | 9.3M +60.92% | |
Income Taxes Payable | 209,644 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 355,000 N/A | 0 -100.00% | 500,000 -6.97% | 537,466 -55.42% | |
Total Current Liabilities | 4.2M +407.40% | 826,764 -89.56% | 7.9M +135.72% | 3.4M +39.79% | |
Total Long-Term Debt | 5.7M +282.06% | 1.5M +67.22% | 892,500 N/A | N/A N/A | |
Total Long-Term Liabilities | 0 -100.00% | 2.5M +0.001% | 2.5M 0.00% | 2.5M 0.00% | |
Total Liabilities | 4.2M +407.40% | 826,764 -92.26% | 10.7M +78.13% | 6.0M +14.81% | |
Retained Earnings | -84.9M +14.05% | -74.4M +5.76% | -70.4M +20.91% | -58.2M +39.55% | |
Total Stockholders Equity | 7.3M +415.51% | 1.4M +115.92% | -8.8M -369.25% | 3.3M +504.89% | |
Total Shares Outstanding | 4.8M +51.84% | 3.2M -91.14% | 35.7M +10.00% | 32.4M +365.93% | |
Cash Flow | |||||
Cash from Operating Activities | -2.8M -35.19% | -4.3M -55.93% | -9.7M -30.22% | -13.9M -7.07% | |
Capital Expenditures | 8,000 +104.24% | 3,917 N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 1.7M +43,500.56% | -3,917 N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.6M -47.83% | 5.0M +208.46% | 1.6M -90.61% | 17.4M -14.46% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -121.36% +24.98% | -97.10% -55.63% | -218.86% -0.22% | -219.34% -35.96% | |
Return on Equity | -191.77% -459.52% | 53.34% -87.83% | 438.42% +150.81% | -862.92% -404.89% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 0.76 -71.82% | 2.69 +1,069.37% | 0.23 -91.64% | 2.75 +15.58% | |
Cash Ratio | 0.52 -73.95% | 2.01 +1,677.93% | 0.11 -95.75% | 2.66 +17.87% | |
Debt-to-Equity Ratio | 0.84 -21.28% | 1.06 +773.35% | -0.16 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.53 -20.81% | 0.67 -11.38% | 0.75 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow